Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Unani medicine offers a natural, effective approach to treating hair loss with minimal side effects, but needs more scientific validation.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.

Excess androgens may cause PCOS, not just be a symptom.

Freeze-drying collagen-activated PRP increases TGF-β1 levels, enhancing tissue regeneration potential.

Androgens increase growth factors in skin cells, which may lead to acne.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

In Pakistan, men with more severe hair loss often have a higher BMI.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Hair loss risk is influenced by multiple genes.

PRP helps hair growth in common hair loss disorder.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

Diffuse alopecia in females is often linked to certain medications, diseases, and low hemoglobin, while female pattern hair loss is linked to age, duration, and family history.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Phototrichogram helps assess hair loss severity.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.